Status:
COMPLETED
Large Cell Lymphoma Pilot Study III
Lead Sponsor:
St. Jude Children's Research Hospital
Conditions:
Lymphoma, Large Cell
Lymphoma, Non-Hodgkin
Eligibility:
All Genders
Up to 18 years
Phase:
NA
Brief Summary
The main purpose of this study is to find out if it is feasible to deliver a multi-agent chemotherapy regimen which features a shorter, more intensive, immunophenotype-directed approach, and includes ...
Detailed Description
Secondary objectives will include documenting the toxicity associated with the treatment regimen, and to estimate the response rates and survival of participants with large cell lymphoma treated on th...
Eligibility Criteria
Inclusion
- Patient must be previously untreated, except for steroids or emergency radiation therapy.
- Patient must be less than or equal to 18 years of age.
- Patient must have a histologic diagnosis of large cell Non-Hodgkin lymphoma.
- The immunophenotype of tumor cells must be either T-cell or non-B-cell, non-T-cell.
Exclusion
- Participants with B-cell immunophenotype NHL.
Key Trial Info
Start Date :
December 1 1997
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2001
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT00187070
Start Date
December 1 1997
End Date
July 1 2001
Last Update
May 7 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Jude Children's Reaearch Hospital
Memphis, Tennessee, United States, 38105